CHEST 2025: GLP-1 Agonists Open New Pathways for Treating Obstructive Sleep Apnea

Matthew Biszewski, PharmD, clinical pharmacist at Endeavor Health, discussed how the FDA’s approval of glucagon-like peptide-1 (GLP-1) for obstructive sleep apnea (OSA) expands access to therapy for patients without diabetes.

During his session…